CA2468678A1 - Modulation de troubles associes aux cellules immunitaires a l'aide de l'il-1hy2 - Google Patents

Modulation de troubles associes aux cellules immunitaires a l'aide de l'il-1hy2 Download PDF

Info

Publication number
CA2468678A1
CA2468678A1 CA002468678A CA2468678A CA2468678A1 CA 2468678 A1 CA2468678 A1 CA 2468678A1 CA 002468678 A CA002468678 A CA 002468678A CA 2468678 A CA2468678 A CA 2468678A CA 2468678 A1 CA2468678 A1 CA 2468678A1
Authority
CA
Canada
Prior art keywords
cell
cells
protein
lhy2
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002468678A
Other languages
English (en)
Inventor
Alice Ho
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2468678A1 publication Critical patent/CA2468678A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/245—IL-1

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne des matériels et des méthodes d'utilisation de compositions comprenant le polypeptide de l'IL-1Hy2 ou des inhibiteurs de l'activité de l'IL-1Hy2 pour le traitement de troubles associés aux cellules immunitaires.
CA002468678A 2001-11-29 2002-11-26 Modulation de troubles associes aux cellules immunitaires a l'aide de l'il-1hy2 Abandoned CA2468678A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33448701P 2001-11-29 2001-11-29
US60/334,487 2001-11-29
PCT/US2002/038113 WO2003048376A2 (fr) 2001-11-29 2002-11-26 Modulation de troubles associes aux cellules immunitaires a l'aide de l'il-1hy2

Publications (1)

Publication Number Publication Date
CA2468678A1 true CA2468678A1 (fr) 2003-06-12

Family

ID=23307435

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002468678A Abandoned CA2468678A1 (fr) 2001-11-29 2002-11-26 Modulation de troubles associes aux cellules immunitaires a l'aide de l'il-1hy2

Country Status (4)

Country Link
EP (1) EP1573029A2 (fr)
AU (1) AU2002357030A1 (fr)
CA (1) CA2468678A1 (fr)
WO (1) WO2003048376A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2977384A1 (fr) * 2014-07-25 2016-01-27 Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. Interleukin-38 tronqué à l'extrémité N-terminale
EP3400962A1 (fr) * 2017-05-09 2018-11-14 Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. Inhibiteurs de l'il-38 destinés à être utilisés dans le traitement et/ou la prévention du cancer chez un sujet

Also Published As

Publication number Publication date
WO2003048376A2 (fr) 2003-06-12
AU2002357030A1 (en) 2003-06-17
WO2003048376A9 (fr) 2009-03-05
EP1573029A2 (fr) 2005-09-14

Similar Documents

Publication Publication Date Title
US6337072B1 (en) Interleukin-1 receptor antagonist and recombinant production thereof
JP3825255B2 (ja) 炎症媒介物質のアンタゴニスト
US20030099650A1 (en) Treatment of immune disorders and B cell disorders
JP2008029349A (ja) ヘマトポエチン受容体、ｈｐｒ１およびｈｐｒ２
US6541623B1 (en) Interleukin—1 receptor antagonist and uses thereof
EP1311663B1 (fr) Polypeptides de claudines
US6372892B1 (en) Interleukin—1 Hy2 materials and methods
US6365726B1 (en) Polynucleotides encoding IL-1 Hy2 polypeptides
JP2002510492A (ja) インターロイキン−１レセプターアンタゴニストおよびその使用
JP2003521903A (ja) Ｃｄ８４様ポリペプチドおよびポリヌクレオチドに関する方法と材料
WO2002092762A2 (fr) Polypeptides cytokines
US6294655B1 (en) Anti-interleukin-1 receptor antagonist antibodies and uses thereof
US20070141566A1 (en) Methods and materials relating to novel polypeptides and polynucleotides
US20020156009A1 (en) Novel interleukin - 1 Hy2 materials and methods
CA2468678A1 (fr) Modulation de troubles associes aux cellules immunitaires a l'aide de l'il-1hy2
US6426191B1 (en) Assays involving an IL-1 receptor antagonist
AU2002332429A1 (en) Treatment of immune disorders and B cell disorders
US20020081625A1 (en) Member of the immunoglobulin superfamily and uses thereof
WO2004015078A2 (fr) Procedes et substances se rapportant a de nouveaux polypeptides et polynucleotides de type regulateur de croissance
MXPA04003155A (es) Polipeptidos de citoquina de murino y humano.
MXPA00009515A (en) A interleukin-1 receptor antagonist and uses thereof
AU6053899A (en) Methods and compositions relating to egf-repeat-containing polypeptides
WO2004039942A2 (fr) Procedes et materiaux associes a des polypeptides de type neurotrimine, et polynucleotides
JP2004515206A (ja) 新規なヴォン・ヴィレブランド／トロンボスポンジン様ポリペプチドおよびポリヌクレオチドに関連する方法および材料

Legal Events

Date Code Title Description
FZDE Discontinued